KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Exact Sciences (EXAS) EPS (Basic) (2016 - 2025)

Exact Sciences has reported EPS (Basic) over the past 16 years, most recently at -$0.45 for Q4 2025.

  • Quarterly EPS (Basic) rose 90.36% to -$0.45 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 through Dec 2025, up 80.25% year-over-year, with the annual reading at -$1.1 for FY2025, 80.32% up from the prior year.
  • EPS (Basic) was -$0.45 for Q4 2025 at Exact Sciences, down from -$0.1 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $0.0 in Q3 2023 and troughed at -$4.67 in Q4 2024.
  • The 5-year median for EPS (Basic) is -$0.5 (2025), against an average of -$0.74.
  • Year-over-year, EPS (Basic) surged 100.52% in 2023 and then crashed 4877.87% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at -$1.28 in 2021, then skyrocketed by 43.75% to -$0.72 in 2022, then surged by 62.5% to -$0.27 in 2023, then crashed by 1629.63% to -$4.67 in 2024, then skyrocketed by 90.36% to -$0.45 in 2025.
  • Per Business Quant, the three most recent readings for EXAS's EPS (Basic) are -$0.45 (Q4 2025), -$0.1 (Q3 2025), and -$0.01 (Q2 2025).